Evaluation of molecular detection for respiratory syncytial viruses in World Health Organization Europe region laboratories, 2020–2023
Based on analysis of data from the QCMD RSV EQA program during the years 2020-2023, we conclude molecular diagnostics for RSV in laboratories from WHO Europe region are being performed with high-quality. However, with increases in testing, numerous diagnostic assays being used by laboratories, and possible viral changes to newly introduced vaccines and prophylactic/therapeutic antibodies, continued quality assessment of RSV diagnostics is recommended.
Authors
- Elaine McCulloch
- Lance Presser (ORCID: https://orcid.org/0000-0003-3610-3215)
- Adam Meijer (ORCID: https://orcid.org/0000-0001-8074-7582)
- Amani Yousef
- Julia Schaumburg
Institutions
- Tinbergen Institute (NL)
- National Institute for Public Health and the Environment (NL)
- Industrial Systems and Control (United Kingdom) (GB)
- 3dMD (United Kingdom) (GB)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Journal of Clinical Virology
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1016/j.jcv.2025.105832
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Federation of Pharmaceutical Industries and Associations
- Innovative Medicines Initiative
- Horizon 2020 Framework Programme